| Financial Year |
March 31 2023 |
| Monetary Funds |
147,126,389.89 |
| Held-for-trading Financial Assets |
21,226,301.37 |
| Notes Receivable |
-- |
| Accounts Receivable |
162,111,186.96 |
| Advances to Suppliers |
25,581,963.70 |
| Other Receivables |
19,573,762.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
295,176,073.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,109,916.38 |
| Total Current Assets |
704,892,643.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
66,770,957.24 |
| Investment Properties |
-- |
| Fixed Assetes |
566,497,877.35 |
| Under-construction Projects |
59,360,560.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,126,120.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,368,964.87 |
| Deferred Income Tax Assets |
39,543,746.17 |
| Other Non-Current Assets |
2,228,944.14 |
| Sub-Total of Non-Current Assets |
785,209,859.15 |
| Total Assets |
1,490,102,502.58 |
| Short-Term Loans |
478,484,454.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
54,500,000.00 |
| Accounts Payable |
211,744,906.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,987,989.48 |
| Taxes Payable |
-- |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
-- |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,656,557.84 |
| Other Current Liabilities |
23,994,165.69 |
| Sub-Total of Current Liabilities |
827,951,232.80 |
| Long-term Loans |
16,587,109.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,679,345.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,090,289.67 |
| Total Liabilities |
856,041,522.47 |
| Paid-In Capital(Or Share Stock) |
292,474,000.00 |
| Capital Surplus |
120,748,650.87 |
| Surplus Reserve |
41,843,366.60 |
| LESS:Treasury Stock |
18,601,440.00 |
| Undistributed Profits |
193,781,941.10 |
| Minority Stockholder's Interest |
3,476,863.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
630,584,117.00 |
| Owner's Equity（Stockholder's Equity） |
634,060,980.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,490,102,502.58 |
